UiPath's robust AI-driven automation platform, strong earnings beats, and 16% YoY revenue growth highlight its upward trajectory. Read why PATH stock is a strong buy.

So I wrote an epic missive on the absurdity of AI agent overhype, hopped on a plane to Vegas, to hear UiPath make splashy news announcements about... AI agents. How did that go over with me? A bit ...

UiPath Inc. today announced a preview of its upcoming Agent Builder tool as it outlined its vision to combine its expertise in robotic process automation with generative artificial intelligence models ...

UiPath remains a buy, outperforming the S&P 500 with a 53.6% gain since March 2025, driven by operational turnaround. PATH's revenue growth re-accelerated to 15.9% in Q3 FY26, with raised full-year ...

What’s the next big thing in enterprise automation? If you ask the tech giants, it’s agents — driven by generative AI. There’s no universally accepted definition of agent, but these days the term is ...

At UiPath's annual conference this week, the keynote focused on the potential of automation to reshape how organizations operate at scale. Speakers from companies like Omega Healthcare and Canon ...

AI headlines tend to focus on the same household names, but the most compelling opportunities are often hiding in plain ...

UiPath Inc. (NYSE:PATH) is one of the best AI stocks to buy according to hedge funds. On June 25, UiPath announced a significant internal transformation of its Enterprise Resource Planning/ERP system.

Back in early 2021, it seemed everything was going right for UiPath. At a time when there were a number of high-flying enterprise startups, UiPath was at the top of the heap when it raised $750 ...

UiPath's robotic process automation platform was under threat from AI. The company has combined the two technologies to offer a unified automation platform. UiPath is back on track and is now set to ...